Pozen, Inc. Announces September 5th Webcast to Discuss the PA8140/PA32540 Exclusive U.S. License Agreement

POZEN Inc. (NASDAQ:POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that it plans to hold a live webcast on September 5, 2013 at 11:00 a.m. (ET), with a discussion by POZEN management of the PA8140/PA32540 exclusive U.S. license agreement. The webcast can be accessed on POZEN’s website at www.pozen.com and will be archived and available for replay.

Help employers find you! Check out all the jobs and post your resume.